Evidence map›Paper›PMID 36407214›Full record

ArticleCureus2022

Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment.

Kenta Torigoe, Yuta Ikemi, Yuki Yoshida, Ryosuke Sakamoto, Ayuko Yamashita, Shinichi Abe, Kumiko Muta, Hideyuki Arai, Hiroshi Mukae, Tomoya Nishino

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kenta TorigoeNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Yuta IkemiNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Yuki YoshidaNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Ryosuke SakamotoNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Ayuko YamashitaNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Shinichi AbeNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Kumiko MutaNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Hideyuki AraiInternal Medicine, Kusumoto Naika Clinic, Omura, JPN.
Hiroshi MukaeRespiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JPN.
Tomoya NishinoNephrology, Nagasaki University Hospital, Nagasaki, JPN.
Nagasaki University Hospital · JPUniversity of Nagasaki · JPOtsuka Pharmaceutical (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 76-year-old Japanese man with nephrotic syndrome was admitted to our department for treatment. After his admission, he was administered prednisolone (PSL) at 40 mg/day, and a percutaneous renal biopsy was performed. However, on the first day of admission, his urinary protein decreased from 5.05 g/gCr to 1.85 g/gCr. On the fourth day of admission, his urinary protein further decreased to 0.38 g/gCr and the patient developed acute kidney injury (AKI). Renin-angiotensin system (RAS) inhibitors were suspected to be the cause of AKI; therefore, they were discontinued. After the renal function improved, the urinary protein worsened again to 5.49 g/gCr. Renal pathology suggested minimal change disease (MCD); therefore, PSL was continued. The patient's urinary protein subsequently improved and he had no renal function impairment. Minimal change disease can be complicated by AKI through intravascular volume depletion caused by high urinary protein and hypoalbuminemia. However, when MCD is complicated by RAS inhibitor-associated AKI, the urinary protein may notably decrease, and the patient may present with an atypical course of MCD-associated AKI.

Indexed as

acute kidney injuryhypoalbuminemiaminimal change diseaseprimary nephrotic syndromerenin–angiotensin system inhibitors

Identifiers

PMID36407214
PMCPMC9665908
OpenAlexW4306353459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.